Premium
Prognosis of Subjects in the Framingham Study With Rheumatic Heart Disease
Author(s) -
Goetzler Renee,
Stokes Joseph,
Anderson Keaven
Publication year - 1985
Publication title -
journal of the american geriatrics society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 232
eISSN - 1532-5415
pISSN - 0002-8614
DOI - 10.1111/j.1532-5415.1985.tb01778.x
Subject(s) - medicine , framingham heart study , heart disease , etiology , cohort , framingham risk score , rheumatic fever , disease , cohort study , cardiology , valvular heart disease , physical therapy
One hundred thirteen of the original Framingham Heart Study cohort, aged 30 to 62 years, were identified as having valvular heart disease of presumed rheumatic etiology. All of these subjects, and a sample of age‐ and sex‐matched controls, were accounted for during 34 years between 1950 and 1984. Although subjects with rheumatic heart disease had significantly higher mortality and serious morbidity than did those in the control group, 36 of the 113 (31.9%) rheumatic heart disease subjects survived at the end of this period as compared with 52.7% of the control subjects.